AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 173 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $162,000 | +39.7% | 12,239 | +151.6% | 0.00% | 0.0% |
Q2 2016 | $116,000 | +16.0% | 4,864 | +13.8% | 0.00% | 0.0% |
Q1 2016 | $100,000 | +3.1% | 4,275 | +33.6% | 0.00% | 0.0% |
Q4 2015 | $97,000 | -41.6% | 3,201 | -23.4% | 0.00% | 0.0% |
Q3 2015 | $166,000 | +137.1% | 4,177 | +312.3% | 0.00% | 0.0% |
Q2 2015 | $70,000 | -82.6% | 1,013 | -86.3% | 0.00% | -66.7% |
Q1 2015 | $403,000 | +1579.2% | 7,375 | +1212.3% | 0.00% | – |
Q4 2014 | $24,000 | +14.3% | 562 | -15.6% | 0.00% | – |
Q3 2014 | $21,000 | +75.0% | 666 | +10.6% | 0.00% | – |
Q2 2014 | $12,000 | 0.0% | 602 | 0.0% | 0.00% | – |
Q1 2014 | $12,000 | -20.0% | 602 | -0.8% | 0.00% | – |
Q4 2013 | $15,000 | -65.1% | 607 | -69.7% | 0.00% | – |
Q3 2013 | $43,000 | +79.2% | 2,002 | +81.8% | 0.00% | – |
Q2 2013 | $24,000 | – | 1,101 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,921,550 | $81,254,000 | 4.00% |
Palo Alto Investors LP | 1,614,536 | $33,453,000 | 2.49% |
Ghost Tree Capital, LLC | 100,000 | $2,072,000 | 1.46% |
March Altus Capital Management LP | 146,418 | $3,034,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 296,458 | $6,143,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,339 | $20,706,000 | 0.83% |
Visium Asset Management, LP | 2,070,870 | $42,908,000 | 0.67% |
AlphaOne Investment Services, LLC | 97,448 | $2,019,000 | 0.54% |
CONTINENTAL ADVISORS LLC | 57,438 | $1,190,000 | 0.28% |
Tamarack Capital Management, LLC | 64,080 | $1,222,000 | 0.25% |